| Chen, Xin |
OPTIMA-6, NCT05410925: Efficacy and Safety of a Half-dose Bolus of r-SAK Prior to Primary PCI in ST-elevation Myocardial Infarction |
|
|
| Recruiting | 4 | 2260 | RoW | Recombinant staphylokinase, Placebo | The First Affiliated Hospital with Nanjing Medical University | ST Elevation Myocardial Infarction | 12/26 | 12/27 | | |
NCT05182463: Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients |
|
|
| Recruiting | 4 | 5000 | RoW | Peginterferon Alfa-2B, Nucleoside Analogs | Third Affiliated Hospital, Sun Yat-Sen University | Hepatitis B, Chronic | 12/26 | 11/29 | | |
| Recruiting | 4 | 210 | RoW | Realgar Indigo naturalis formula, RIF, Conventional chemotherapy | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital, Sun Yat-Sen University, Third Affiliated Hospital, Sun Yat-Sen University, Zhujiang Hospital, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou First People's Hospital, Huizhou Municipal Central Hospital, First Affiliated Hospital of Shantou University Medical College, Zhongshan People's Hospital, Guangdong, China, Zhongshan Bo Ai Hospital, First Affiliated Hospital of Guangxi Medical University, LiuZhou People's Hospital, Second Xiangya Hospital of Central South University, Hainan People's Hospital | Arsenic Trioxide, Childhood ALL | 09/27 | 09/30 | | |
TQB2450-III-09, NCT04964479: A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC) |
|
|
| Recruiting | 3 | 375 | RoW | TQB2450 injection, Anlotinib Hydrochloride Capsules, Pembrolizumab injection, Placebo | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Non Small Cell Lung Cancer | 12/22 | 03/23 | | |
NCT05003245: Compare the Efficacy and Safety of HLX04-O With Ranibizumab in Subjects With wAMD |
|
|
| Recruiting | 3 | 388 | RoW | HLX04-O，recombinant anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody ophthalmic injection, Lucentis | Shanghai Henlius Biotech | Age Related Macular Degeneration | 08/23 | 03/24 | | |
NCT06301854: Long-term Safety of TPN171H Tablet in Erectile Dysfunction. |
|
|
| Recruiting | 3 | 472 | RoW | TPN171H, Simmerafil | Vigonvita Life Sciences | Erectile Dysfunction | 04/25 | 04/25 | | |
NCT04937387: Efficacy and Safety of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) in Chinese Participants With Inadequately Controlled Asthma |
|
|
| Completed | 3 | 359 | RoW | FF/VI, FF/UMEC/VI, ELLIPTA | GlaxoSmithKline | Asthma | 08/24 | 08/24 | | |
| Recruiting | 2 | 30 | RoW | Mitoxantrone hydrochloride liposome, Venetoclax, Cytarabine,Cytosine arabinoside, Cyclophosphamide | Institute of Hematology & Blood Diseases Hospital, China | Relapse Acute Myeloid Leukemia | 05/27 | 10/27 | | |
| Recruiting | 1/2 | 60 | RoW | PM8002, nab-paclitaxel | Biotheus Inc. | TNBC | 10/26 | 10/26 | | |
NCT05001412: Chemotherapy Combined With Camrelizumab and Apatinib in First-line Treatment of ES-SCLC |
|
|
| Recruiting | 1 | 36 | RoW | Camrelizumab; apatinib; carboplatin; etoposide | Zhou Chengzhi, Jiangsu Hengrui Pharmaceutical Co., Ltd. | Extensive Stage Small Cell Lung Cancer | 01/23 | 01/24 | | |
NCT04613115: Relationship Between Arterial Variations and Patency of Arteriovenous Fistulae |
|
|
| Completed | N/A | 1000 | RoW | | Beijing Tongren Hospital | Arteriovenous Fistula, Ultrasound, Artery | 06/21 | 06/22 | | |
GIANT, NCT04765592: Guo's Aortic Arch Reconstruction :The Prospective ,Multiple Center Study About the Safety and Efficacy of WeFlow-Arch Modeler Embedded Branch Stent Graft System ( Study) |
|
|
| Active, not recruiting | N/A | 88 | RoW | WeFlow-Arch Modeler Embedded Branch Stent Graft System | Hangzhou Endonom Medtech Co., Ltd. | Aortic Arch Aneurysm | 02/25 | 02/29 | | |
PLACARD, NCT06336239: PrevaLence of Albuminuria in Patients With CARdiovascular Disease and Type 2 Diabetes Mellitus in China: a National Cross-sectional Study |
|
|
| Recruiting | N/A | 3000 | RoW | | Beijing Anzhen Hospital | Cardiovascular Disease, Type 2 Diabetes Mellitus | 07/24 | 12/24 | | |
GRAFT, NCT05754541: Guo's Endovascular Aortic Arch Replacement of Aortic Dissection by WeFlow-Tribranch Endoprothesis: a Multicenter Pilot Study( Study) |
|
|
| Recruiting | N/A | 20 | RoW | WeFlow-Tribranch Aortic Arch Stent Graft System | Hangzhou Endonom Medtech Co., Ltd. | Aortic Aneurysm and Dissection | 12/23 | 12/25 | | |
NCT05021601: Bi-atrial Versus Left Atrial Ablation for Patients With Rheumatic Mitral Valve Disease and Non-paroxysmal Atrial Fibrillation |
|
|
| Recruiting | N/A | 320 | RoW | Bi-atrial ablation, Left atrial ablation | China National Center for Cardiovascular Diseases | Persistent Atrial Fibrillation | 06/25 | 07/25 | | |
NCT06385379: Guo's Aortic Arch Reconstruction: A Multicenter, Prospective Study of the Novel WeFlow-Tribranch System (GENIUS Study) |
|
|
| Recruiting | N/A | 90 | RoW | WeFlow-Tribranch embedded aortic Triple-branch arch Stent Graft system | Hangzhou Endonom Medtech Co., Ltd. | Aortic Arch Aneurysm | 12/25 | 12/30 | | |
| Recruiting | N/A | 480 | RoW | Usual care, POST-strategy | Istituto Auxologico Italiano | Hypertension,Essential, Hypertension, Uncontrolled | 12/24 | 12/24 | | |
| Not yet recruiting | N/A | 2000 | RoW | | China-Japan Friendship Hospital, Second Affiliated Hospital of Xi'an Jiaotong University, First Hospital of China Medical University, Henan Provincial People's Hospital, Second Xiangya Hospital of Central South University, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Sichuan University, Ruijin Hospital Affiliated to Shanghai Jiao Tong University, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China | Chronic Obstructive Pulmonary Disease (COPD), Asthma, Bronchiectasis | 07/28 | 07/28 | | |
| Recruiting | N/A | 1017 | US, RoW | Infuse™ Bone Graft (Infuse™), Intervertebral body fusion device and Medtronic posterior Fixation Systems | Medtronic Spinal and Biologics | Degenerative Disease of the Lumbosacral Spine | 04/26 | 04/28 | | |
| Active, not recruiting | N/A | 255 | RoW | EDWARDS INSPIRIS RESILIA Aortic Valve | Edwards Lifesciences, Edwards (Shanghai) Lifesciences Medical Supplies Co., Ltd., Rundo International Pharmaceutical Research & Development Co.,Ltd., Fuwai Hospital, CAMS & PUMC | Aortic Valve Replacement | 12/28 | 12/29 | | |
NCT05376618: Pilot Study on Proteomics of Erythrocyte Proteins in Patients With COPD Based on TMT Technology |
|
|
| Completed | N/A | 30 | RoW | no intervention | Zhujiang Hospital | Protein; Disease | 07/22 | 07/22 | | |
| Wang, Liqing |
NCT04524039: iTBS Study for Depression in Patients With Multiple Sclerosis |
|
|
| Not yet recruiting | N/A | 30 | NA | intermittent theta burst stimulation using a MagPro X100, sham intermittent theta burst stimulation using a MagPro X100 | Third Affiliated Hospital, Sun Yat-Sen University | Multiple Sclerosis, Depression, Anxiety | 09/22 | 12/22 | | |
| Duan, Chuanzhi |
NCT06308952: Effectiveness of Atorvastatin in Preventing Cerebrovascular Events After Flow Diverter Implantation |
|
|
| Recruiting | 4 | 386 | RoW | Atorvastatin 20mg, Lipitor | Duan Chuanzhi | Cerebrovascular Event, Stent Stenosis, Ischemic Stroke, Hemorrhagic Stroke, Stent Thrombosis, Death, Brain, Endothelial Dysfunction | 08/27 | 08/27 | | |
| Not yet recruiting | 2 | 40 | RoW | Bevifibatide citrate injection, BETAGRIN | Zhujiang Hospital | Ischemic Stroke, Acute, Ischemic Stroke, Cerebral Infarction, Brain Diseases | 09/25 | 12/25 | | |
NCT06456814: Epidemiological Insights Into the Formation, Progression, and Rupture of Intracranial Aneurysms: A Retrospective, Multi-Center Hospital-Based Study in China |
|
|
| Recruiting | N/A | 30000 | RoW | | Zhujiang Hospital, Beijing Tiantan Hospital, Guangdong Provincial People's Hospital, First Affiliated Hospital of Chongqing Medical University, The Affiliated Hospital Of Southwest Medical University | Intracranial Aneurysm, Subarachnoid Hemorrhage, Aneurysmal, Cerebral Aneurysm, Brain Aneurysm | 06/24 | 12/26 | | |
EMPOWER, NCT04289480: Safety and Effectiveness of ENTERPRISE 2 Device in the Endovascular Treatment of Intracranial Aneurysms |
|
|
| Active, not recruiting | N/A | 164 | RoW | ENTERPRISE 2 device | Medos International SARL, Johnson & Johnson Medical (Shanghai) Ltd. | Intracranial Aneurysm | 04/22 | 01/27 | | |
NCT06446778: Pipeline Embolization for Intracranial Aneurysms |
|
|
| Recruiting | N/A | 1000 | RoW | Pipeline embolization device with or without shield technique | Zhujiang Hospital, Nanfang Hospital, Southern Medical University, Eighth Affiliated Hospital, Sun Yat-sen University, Zhongshan Hospital Of Traditional Chinese Medicine, First Affiliated Hospital of Jinan University, Beijing Tiantan Hospital, First Affiliated Hospital of Chongqing Medical University, Affiliated Hospital of Southwest Medical University, Guangdong 999 Brain Hospital, Shantou Central Hospital, Guangdong Provincial People's Hospital, The First Affiliated Hospital of Zhengzhou University, First Affiliated Hospital of Harbin Medical University | Efficacy, Self, Hemodynamic Instability, Stenosis, Aneurysm, Intracranial | 09/27 | 09/30 | | |
NCT05058482: Non-adhesive Liquid Embolic System in the Embolization of Cerebral Arteriovenous Malformations |
|
|
| Recruiting | N/A | 116 | RoW | embolism | Suzhou Hengruihongyuan Medical Technology Co. LTD | Intracranial Arteriovenous Malformations | 10/23 | 10/24 | | |
NCT05898893: PARAT PLUS (The Tubridge Plus For The Treatment Of Wide-Necked Intracranial Aneurysms) |
|
|
| Recruiting | N/A | 99 | RoW | Microport NeuroTech Tubridge Plus flow-diverter Stent | MicroPort NeuroTech Co., Ltd. | Intracranial Aneurysm | 03/24 | 12/24 | | |
NCT06479343: Efficacy and Safety of the Liquid Embolic System (Tonbridge) for Endovascular Treatment of Cerebrovascular Malformations |
|
|
| Recruiting | N/A | 170 | RoW | Liquid Embolic System (Tonbridge), Onyx Liquid Embolic System (Medtronic) | Zhuhai Tonbridge Medical Tech. Co., Ltd. | Intracranial Arteriovenous Malformations | 10/25 | 10/26 | | |
NCT05755516: Efficacy and Safety of the Self-expanding Intracranial Stent (Tonbridge) for Endovascular Treatment of Intracranial Aneurysms |
|
|
| Active, not recruiting | N/A | 204 | RoW | Self-expanding Intracranial Stent (Tonbridge), LVIS and LVIS Jr. (MicroVention) | Zhuhai Tonbridge Medical Tech. Co., Ltd. | Intracranial Aneurysm | 10/24 | 04/25 | | |
| Yang, Pingzhen |
| No trials found |
| Guang, Sun Y |
| No trials found |
